Here's the Latest
from Inteliquet

“Precision medicine has emerged as a promising approach to healthcare, tailoring treatments to the...

“Instead of waiting five years for a clinical trial to be designed, enrolled, and completed, what if it could be done in 1/5 of the time?

“Q: What important company milestone do you anticipate reaching in 2022?

“Q: What’s the key to being a leader in the industry?

“Clinical Trial Candidates Are Not Being Identified Early Enough

“Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?

“Q: For what therapeutic area do you think we will see the greatest progress in the coming years?

“Marie Lamont, General Manager of Inteliquet, shares her insights on why clinical trials as a care option is so important, how to employ creative tension to build high-performing teams, and how to thoughtfully and purposefully build a network can lead to career success.

“Advances In Precision Medicine And Artificial Intelligence Are Set To Transform Cancer Treatment

“Interest BioPharma and Other Sponsors in YOUR Investigator Initiated Trials

“Cancer Centers can Leverage Data Operations to Overcome Post-pandemic Clinical Trial Challenges

“Q: What’s the next “big thing” on the horizon that will significantly alter the pharma/biopharma market, your operations, or the way you do business?